Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Single-Cell Omics Market Grown from 2024 to 2025?

Over the past few years, the single-cell omics market size has experienced rapid expansion. It is projected to increase from $2.08 billion in 2024 to $2.41 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 15.9%. The significant growth during the historic period can be attributed to factors such as the discovery of cellular heterogeneity, the development of single-cell analysis tools, advancements in biomedical research, characterisation of the immune system, and the proliferation of precision medicine.

What Growth Rate Is Anticipated for the Single-Cell Omics Market in the Coming Years?

The size of the single-cell omics market is projected to experience swift expansion in the coming years, reaching a market value of $4.52 billion in 2029 with a CAGR of 17.0%. The surge during the forecast period can be ascribed to its adoption in clinical and diagnostic settings, combination with multi-omics techniques, utilization in regenerative medicine, application in pharmaceutical innovation and discovery, cell therapies, and immunotherapies. Key trends noted during the forecast period consist of in vivo single-cell studies, the use of single-cell omics in investigating infectious diseases, microfluidics in single-cell separation, integration of single-cell multi-omics, and spatial single-cell profiling.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Who Are the Leading Companies in the Single-Cell Omics Market?

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

What Are the Key Drivers of the Single-Cell Omics Market?

The anticipated escalation in cancer prevalence is predicted to fuel the expansion of the single-cell omics market. Cancer encompasses a range of diseases that can originate in virtually any organ or tissue when cells deviate and grow uncontrollably, overreaching their normal limits, and either metastasize to other organs or infiltrate nearby body structures. The utilization of single-cell omics data has been instrumental in the detection of biomarkers for cancer, forecasting prognosis, and uncovering new treatment targets in pre-established clinical cohorts. For example, the National Institutes of Health, a government agency based in the US, stated in May 2024 that around 18.1 million US residents were living as cancer survivors as of January 2022. This figure is projected to ascend to 22.5 million by 2032. Consequently, the increasing prevalence of cancer is steering the growth of the single-cell omics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

What Are the Key Market Segments in the Single-Cell Omics Industry?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

What Are the Latest Trends in the Single-Cell Omics Market?

The trend of product innovation is rapidly growing within the single-cell omics market. The primary companies within this market are developing trailblazing products in order to secure and maintain their market standing. An example of this is Deepcell, a United States-based software company focusing on single-cell dimensional morphology analysis. In May 2023, Deepcell launched the REM-I Platform, a versatile single-cell imaging, in-depth analysis, and cell sorting platform. This groundbreaking product offers novel insights into cell biology that were previously unobtainable. The REM-I Platform is fostering fresh avenues for discoveries in a variety of fields such as cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening among others. This is achieved by amalgamating single-cell imaging, sorting, and extensive dimensional analysis.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

What Are the Key Regional Markets in the Single-Cell Omics Industry?

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12379

This Report Delivers Insight On:

1. How big is the single-cell omics market, and how is it changing globally?

2. Who are the major companies in the single-cell omics market, and how are they performing?

3. What are the key opportunities and risks in the single-cell omics market right now?

4. Which products or customer segments are growing the most in the single-cell omics market?

5. What factors are helping or slowing down the growth of the single-cell omics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model